Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04126876
Title A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma (INTRIM)
Acronym INTRIM
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors A.J.M. van den Eertwegh
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD


No variant requirements are available.